StockVS

纳斯达克 · 资产管理 · USD

The Carlyle Group Inc. (CG) 股票分析

The Carlyle Group Inc.(CG)是在纳斯达克上市的资产管理股票,以美元交易。

CG

$46.97

−$0.78 (−1.63%)

2026年9月4日 · 收盘

比较

价格走势

悬停查看每日收盘价。虚线表示区间起始价。

将CG与其他标的对比… →

CG 关键统计数据

数据截至2026年9月4日
交易
开盘价
$46.90
前收盘价
$47.75
当日波动区间
46.50–47.61
52周波动区间
39.60–69.85
成交量
1.94M
Beta系数股价相对大盘的波动幅度。1.0与大盘同步,高于1.0波动更大,低于1.0更小。
1.83
估值
市值
$167.37亿
市盈率
48.93
预期市盈率股价除以未来一年的预测盈利,而非过去一年的实际盈利。
9.19
PEG比率市盈率除以预期盈利增长率。把高市盈率放在增长速度的背景下衡量。
0.81
市销率市值除以年营业收入。适用于尚未盈利、无法计算市盈率的公司。
5.98
每股收益(近12个月)过去十二个月归属于每股的利润。
0.96
财务(财年)
营业收入(财年)
$32.13亿−5.56%
净利润(财年)
$8.09亿−20.75%
净利率扣除全部成本和税费后,营业收入中作为利润留存的比例。
13.01%
流通股数所有投资者持有的股份总数。市值即该数量乘以股价。
356.33M
一年回报率
−26.17%
股息与日期
股息
$1.40+2.93%
除息日
2026年9月30日
财报日期
2026年10月29日预计
平均成交量
3.61M

仅显示公司披露的指标。 数据由Yahoo Finance通过yfinance提供。每日更新。

CG 历年回报率

历年回报率根据每日收盘价计算。 不完整年度以浅色显示并标有星号。

年份回报率
2026 (不完整年度)−19.44%
2025+20.20%
2024+28.05%
2023+42.55%
2022−43.78%
2021+78.46%
2020+1.62%
2019+116.75%
2018−27.28%
2017+59.83%
2016 (不完整年度)−2.74%

数据截至2026年9月4日。

CG 各财年营收与利润

财年截至十二月
财年营业收入净利润净利率
2025$32.13亿$8.09亿25.2%
2024$34.02亿$10.20亿30.0%
2023$13.24亿−$6.08亿−45.9%
2022$33.55亿$12.25亿36.5%
财年营业收入毛利营业利润净利润净利率
2025$32.13亿$8.09亿25.2%
2024$34.02亿$10.20亿30.0%
2023$13.24亿−$6.08亿−45.9%
2022$33.55亿$12.25亿36.5%

为公司报告货币口径的年度公布数据。 数据截至2025年12月31日。

CG 股息历史

$1.40+0.0% 较2024年

2025年每股股息 · 4次派息

年份每股股息派息次数同比变化
2026*$1.053
2025$1.404+0.0%
2024$1.404+1.8%
2023$1.384+12.2%
年份每股股息派息次数同比变化
2026 (不完整年度)$1.053
2025$1.404+0.0%
2024$1.404+1.8%
2023$1.384+12.2%
2022$1.234+22.5%
2021$1.004+0.0%
2020$1.004−26.5%
2019$1.364+9.7%
2018$1.244+0.0%
2017$1.244+148.0%
2016$0.501

最近一次派息:每股$0.35,除息日2026年8月17日。 按除息日汇总的每股金额,以自然年计。 不完整年度以浅色显示并标有星号。

CG估值与资产管理中位数对比

561只股票的中位数
指标CG资产管理中位数相对中位数
市盈率48.9310.34中位数的4.7倍
市销率5.9810.42低43%
净利率13.01%24.09%低11.1个百分点

基于561只披露该指标的资产管理股票的中位数。采用中位数而非平均值,异常值不会扭曲结果。 数据截至2026年9月4日。

最新新闻

全部14篇文章 ↓

新闻由第三方来源提供。不构成投资建议。

分析

数据生成

公司概述

The Carlyle Group Inc.(CG)的市值为$167.37亿。该公司归入金融服务板块下的资产管理行业。公司公布的员工人数为2,500人。

过去52周,价格在$39.60至$69.85之间波动。记录中CG的最新收盘价为$46.97,日期为2026年9月4日。与前一交易日收盘价相比为−$0.78(−1.63%)。最新收盘价较该52周最低价高出18.61%。

财务健康

2025财年的营业收入为$32.13亿。这较上一财年变化−5.56%,上一财年营业收入为$34.02亿。同年的净利润为$8.09亿。这较上一财年变化−20.75%。净利率为13.01%。这较资产管理中位数24.09%低11.1个百分点。以近十二个月计算,每股收益为0.96。

记录中的4个财年里,营业收入从2022财年的$33.55亿变为2025财年的$32.13亿。记录中的4个财年里,有3个年度净利润为正。

估值评估

按滚动盈利计算,股价相当于盈利的48.93倍。这是资产管理中位数10.34倍的4.7倍。记录中的预期市盈率为9.19倍。PEG比率将市盈率与预期盈利增长率相对比,数值为0.81。以营业收入衡量,股价相当于营业收入的5.98倍。在市销率上,这较资产管理中位数10.42倍低42.57%。共有561家资产管理公司披露这些指标,文中引用的中位数即来自该组。

公布的贝塔系数为1.83。过去10年的日回报率年化后,波动率为37.66%。近一年的价格回报率为−26.17%。以10年衡量,相当于按复利计算每年+16.51%。

增长与收益

CG派发股息,股息率为2.93%。这较资产管理中位数股息率8.11%低5.2个百分点。按公布的派息水平计算,每股每年为$1.40。记录中的除息日为2026年9月30日。股息记录覆盖11个自然年;2026年共派息3次,每股合计$1.05。前一年即2025年,每股合计$1.40。

2026年年初至今的价格变动为−19.44%。记录中表现最强的完整自然年是2019年,为+116.75%;最弱的是2022年,为−43.78%。记录中的9个完整自然年里,有7个年度收涨。

同行比较

The Carlyle Group Inc. (CG) 在资产管理行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
The Carlyle Group Inc. CG $167.37亿 48.9
BlackRock, Inc. BLK $1823.45亿 26.9
Blackstone Inc. BX $1627.40亿 30.5
KKR & Co. Inc. KKR $994.98亿 34.4

资产管理行业平均市盈率为10.3倍。The Carlyle Group Inc.的市盈率为48.9。

以上所有数字均在每晚重新生成时从本页自身的数据中读取。仅供参考,不构成投资建议。 数据截至2026年9月4日。

相关资产管理股票

查看所有资产管理股票 →

金融服务热门股票

查看所有金融服务股票 →

关于The Carlyle Group Inc.

The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES, recapitalization. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies, supply chains, aftermarket services, cybersecurity and digital resilience, digital transformation. Within healthcare, biotech and medtech innovation, life sciences, healthcare IT, pharmacy, pharma commercialization. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, Hong Kong, South East Asia, Indonesia, Philippines, Malaysia, Singapore, Vietnam, Taiwan, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $2.24 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $50 million and $300 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices across North America, South America, Asia, Australia and Europe.

公司简介以英文显示。

访问官网 →